Personalised cancer therapies: why we may never reach the promised land

Anna Wagstaff

New technologies offer wonderful possibilities for cancer patients. But the development of personalised therapies is being squeezed between the priorities of industry and a regulatory system that offers poor value for money. Is there a champion to clear a route to this revolution in treatment?

Download full article

Be the first to comment

Leave a Reply

Your email address will not be published.


*


UA-77507851-1